Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BlueRock, Sloan Kettering Receive IND Clearance for DA01 for Parkinson’s Disease

americanpharmaceuticalreviewJanuary 14, 2021

Tag: BlueRock , Sloan Kettering , Parkinson’s , DA01

PharmaSources Customer Service